Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG667543 Activators

Vomeronasal 1 receptor 257 activators are chemical compounds that can influence specific signaling mechanisms to enhance the functional activity of the receptor. Forskolin, by directly stimulating adenylyl cyclase, increases the intracellular concentration of cAMP, a pivotal secondary messenger in GPCR signaling. This rise in cAMP can lead to the activation of protein kinase A (PKA), which may phosphorylate downstream proteins to enhance the signaling cascade associated with vomeronasal 1 receptor 257. Similarly, IBMX raises cAMP levels by inhibiting its degradation, thereby sustaining the activation state of pathways linked to vomeronasal 1 receptor 257. Zinc acetate and Magnesium chloride supply essential metal ions that act as cofactors for various enzymes involved in receptor signaling. Zinc ions can modulate receptor activity, while magnesium ions are vital for the activation of GTPases, enhancing the signaling efficacy of vomeronasal 1 receptor 257.

Compounds like Sodium orthovanadate and Potassium chloride modulate the phosphorylation status of proteins and membrane potential, respectively, which can indirectly impact the activity of vomeronasal 1 receptor 257. Calcium chloride's role in increasing intracellular calcium levels can activate calcium-dependent kinases and phosphatases that are crucial for the signaling pathways involving vomeronasal 1 receptor 257. Sodium fluoride, by maintaining the activation of G proteins, and nitric oxide donors, by modulating GPCR activity, can amplify the signaling processes of the receptor.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

L-Cysteine

52-90-4sc-286072
sc-286072A
sc-286072B
sc-286072C
sc-286072D
25 g
100 g
500 g
5 kg
10 kg
$51.00
$112.00
$449.00
$1151.00
$2178.00
1
(1)

L-Cysteine can enhance the activity of vomeronasal 1 receptor 257 by increasing glutathione levels, which in turn can protect the receptor from oxidative damage and maintain its conformation for ligand binding.

Copper(II) sulfate

7758-98-7sc-211133
sc-211133A
sc-211133B
100 g
500 g
1 kg
$46.00
$122.00
$189.00
3
(1)

Copper(II) sulfate provides copper ions that can act as essential cofactors for various enzymes that modify signaling lipids, potentially enhancing the signaling cascade that vomeronasal 1 receptor 257 is part of.

Manganese(II) chloride beads

7773-01-5sc-252989
sc-252989A
100 g
500 g
$19.00
$31.00
(0)

Manganese(II) chloride supplies manganese, a co-factor for kinases that phosphorylate proteins in signaling pathways, potentially enhancing the signaling activity of vomeronasal 1 receptor 257.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium chloride can inhibit GSK-3 enzymes, which may lead to the enhancement of signaling pathways associated with vomeronasal 1 receptor 257, as GSK-3 can regulate GPCR desensitization.

Cobalt(II) chloride

7646-79-9sc-252623
sc-252623A
5 g
100 g
$64.00
$176.00
7
(1)

Cobalt(II) chloride can stabilize hypoxia-inducible factors (HIFs), which may enhance the signaling pathways that vomeronasal 1 receptor 257 is involved in, especially under conditions of low oxygen.

Cadmium chloride, anhydrous

10108-64-2sc-252533
sc-252533A
sc-252533B
10 g
50 g
500 g
$56.00
$183.00
$352.00
1
(1)

Cadmium chloride introduces cadmium ions that can interact with sulfhydryl groups in proteins, potentially altering signaling pathways and enhancing the activity of vomeronasal 1 receptor 257 by changing the receptor's conformation.

Ammonium Chloride

12125-02-9sc-202936
sc-202936A
sc-202936B
25 g
500 g
2.5 kg
$39.00
$55.00
$150.00
4
(1)

Ammonium chloride can lead to intracellular acidification, potentially enhancing the functional activity of vomeronasal 1 receptor 257 by optimizing the protonation state for receptor activation.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Verapamil blocks voltage-dependent calcium channels, potentially leading to an increase in intracellular calcium that can enhance the signaling of vomeronasal 1 receptor 257 through calcium-dependent signaling pathways.